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The initial step in herpes simplex virus (HSV) entry is binding of virion glycoprotein (g)C and/or gB to cell surface heparan
sulfate. After this initial attachment, gD interacts with cell surface receptor or receptors, and the virion envelope fuses with
the cell membrane. Fusion requires viral glycoproteins gB, gD, gL, and gH, but the cellular factors that participate in or the
pathways activated by viral entry have not been defined. To determine whether signal transduction pathways are triggered
by viral–cell fusion, we examined the association of viral entry with tyrosine phosphorylation of cellular proteins. Using
immunoprecipitation and Western blotting, we found that at least three cytoplasmic host cell proteins, designated p80, p104,
and p140, become tyrosine phosphorylated within 5–10 min after exposure to HSV-1 or HSV-2. However, no phosphorylation
is detected when cells are exposed to a mutant virus deleted in gL that binds but fails to penetrate. Phosphorylation is
restored when the gL-deletion virus is grown on a complementing cell line. Viral entry and the phosphorylation of p80, p104,
and p140 are inhibited when cells are infected with virus in the presence of protein tyrosine kinase inhibitors. Taken together,
these studies suggest that tyrosine phosphorylation of host cellular proteins is triggered by viral entry. © 1999 Academic Press
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fINTRODUCTION
For herpes simplex virus (HSV), entry into cells is a
omplex process involving binding of virus to cell surface
eceptors followed by direct fusion of the virion envelope
ith the cell plasma membrane (Spear, 1993). Binding is
ediated by an interaction between cell surface heparan
ulfate (HS) proteoglycans and viral glycoproteins (g)C
nd/or gB (Gerber et al., 1995; Herold et al., 1991, 1994;
hieh et al., 1992; Williams and Strauss, 1997; WuDunn et
l., 1989). After the initial attachment of virus to cell
urface HS, it has been proposed that gD binds to spe-
ific coreceptor or coreceptors (Johnson et al., 1990;
ohnson and Ligas, 1988; Lee and Fuller, 1993). Recent
ata suggest that there may be several redundant recep-
ors for gD on cell surfaces (Geraghty et al., 1998; Mont-
omeryet al., 1996; Warner et al., 1998; Whitbeck et al.,
997). These include a novel member of the NGF/TNF
eceptor family called herpesvirus entry mediator A
HveA), which may be the principal coreceptor for infec-
ion of human T lymphocytes (Montgomery et al., 1996;
hitbeck et al., 1997); HveB, a member of the immuno-
lobulin superfamily (Warner et al., 1996); and HveC,
nother member of the immunoglobulin superfamily
Geraghty et al., 1998). The relative role of each of these
oreceptors in HSV entry is yet to be determined. More-
ver, whether or how the binding of gC and/or gB to HS
nd the binding of gD to Hve coreceptors promote viral–
ell fusion is also unknown. It has been shown that
1 To whom reprint requests should be addressed at Box 1657. Fax:
a212) 426-4831. E-mail: betsy_herold@smtplink.mssm.edu.
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220iral–cell fusion occurs at physiological pH and can be
locked by neutralizing antibodies and enhanced by the
hemical fusogen polyethylene glycol (Fuller et al., 1989;
uller and Spear, 1987; Spear, 1993; Wittels and Spear,
991). Several virion glycoproteins, including gD, gB, and
etero-oligomers of gH and gL, are required for viral
enetration. The precise role of each of these glycopro-
eins and the cellular factors involved remains unknown.
Many cell surface receptor–ligand interactions trigger
rotein tyrosine phosphorylation and activation of signal
ransduction pathways. For example, the activities of
ibroblast growth factors (FGFs) are mediated by a family
f tyrosine kinase transmembrane receptors, the FGF
eceptors (FGFRs) (Jaye et al., 1992). Differences in the
ctodomain sequence dictate the ligand specificity for
ach receptor, whereas differences in intracytoplasmic
equence determine the biochemical and functional re-
ponses mediated by each receptor. Notably, the inter-
ction of FGFR with FGF requires HS or soluble heparin
s a cofactor (Aviezer et al., 1994; Krufka et al., 1996;
apraeger et al., 1991; Spivak-Kroizman et al., 1994;
ayon et al., 1991). FGF cannot efficiently bind and acti-
ate FGFR on cells that fail to express HS (Rapraeger et
l., 1991).
Interestingly, several studies have shown that bacte-
ial invasion of epithelial cells may be associated with
yrosine phosphorylation and activation of signal trans-
uction pathways. For example, it has been shown that
ntry of Salmonella typhimurium into some epithelial cell
ines stimulates tyrosine phosphorylation of the receptor
or epidermal growth factor (Galan et al., 1992; Pace et
l., 1993). Similarly, entry of Yersinia pseudotuberculosis
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221ROLE OF TYROSINE PHOSPHORYLATION IN HSV ENTRYnto nonphagocytic cells is associated with a signaling
rocess involving tyrosine phosphorylation (Bliska et al.,
993). Listeria monocytogenes activates mitogen-acti-
ated protein kinase during invasion, and a mitogen-
ctivated protein kinase signal transduction pathway
ay be involved in mediating bacterial uptake (Mengaud
t al., 1996; Tang et al., 1994; Velge et al., 1994). More
ecently, studies have suggested that tyrosine phosphor-
lation may play a role in cytomegalovirus (CMV) and
uman immunodeficiency virus entry (Briand et al., 1997;
eay and Baldwin, 1996).
Taken together, the observation that microbial recep-
or-ligand interactions can trigger signal transduction
athways, candidate coreceptors for gD are linked to
hese pathways, and the integral role HS plays in HSV
ttachment and FGF signaling, suggest that HSV entry
ight be associated with activation of signal transduc-
ion pathways. Therefore, these studies were undertaken
o determine whether HSV-1 and HSV-2 entry is linked
ith tyrosine phosphorylation of cellular proteins and
hether phosphorylation facilitates viral entry.
RESULTS
nduction of tyrosine phosphorylation after the
xposure of cells to HSV
To determine whether the exposure of susceptible
pithelial cells to HSV triggered protein-tyrosine phos-
horylation, we used a combination of immunoprecipita-
ion and immunoblotting techniques. Nearly confluent
onolayers of cells were exposed to HSV or control
uffer for 5, 10, or 30 min. Cell lysates were prepared,
nd the cellular proteins were immunoprecipitated and
FIG. 1. Stimulation of cellular protein tyrosine phosphorylation after e
FU/cell of HSV-1(F) (left), HSV-1(17) (middle), or HSV-2(G) (right) for 5, 1
nd Western blots as described in Materials and Methods. Molecular
roteins designated p80, p104, and p140 that are tyrosine phosphorylaubsequently immunoblotted using anti-protein tyrosine fntibodies. The results for HSV-1(F) are shown in Fig. 1
left). Within 5 min of infection, increased tyrosine phos-
horylation of two proteins designated p140 and p80 was
bserved. The increase in tyrosine phosphorylation of
80 was transient and could no longer be observed after
0 min of incubation. In contrast, the increased phos-
horylation of p140 persisted but was most intense 5 min
ostinfection.
To determine whether the observed induction of ty-
osine phosphorylation was serotype or strain specific,
e also examined the effects of exposure of cells to
SV-1(17) and HSV-2(G) on the tyrosine phosphorylation
attern. Results are shown in Fig. 1 (middle and right,
espectively). The brief exposure of Vero cells to HSV-
(17) and HSV-2(G) resulted in a rapid increase in the
evel of tyrosine phosphorylation of the same two pro-
eins, p80 and p140. Increased tyrosine phosphorylation
as also observed for an additional protein with an
stimated molecular mass of 104 kDa (p104). The in-
reased tyrosine phosphorylation of p104 was most ev-
dent 5 min postinfection.
Next, we examined whether the tyrosine phosphory-
ated cellular proteins being detected were membrane
ssociated or cytosolic. Vero cells were infected with
SV-1(F) at an m.o.i. of 10 pfu/cell for 5 min followed by
ellular fractionation into three fractions: cytosolic, mem-
rane, and Triton X-100 insoluble. All three fractions were
nalyzed by immunoprecipitation followed by immuno-
lotting with anti-phosphotyrosine antibodies. As a con-
rol, we also examined the distribution of the membrane-
ssociated fibronectin receptor integrin with anti-integrin
ntibody. The tyrosine phosphorylated proteins p140,
104, and p80 localized predominantly to the cytosolic
re to HSV-1 or HSV-2. Vero cells were mock infected or exposed to 10
min. Cell lysates were prepared and analyzed by immunoprecipitation
standards are indicated on the far left. The arrows indicate the three
er exposure to HSV-1 or HSV-2.xposu
0, or 30
weightraction (Fig. 2), whereas the fibronectin receptor integrin
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222 QIE, MARCELLINO, AND HEROLDocalized to the membrane fraction (data not shown). An
dditional band with an apparent molecular mass of 98
Da was also observed after cellular fractionation and
ocalized predominantly to the cytosolic fraction. The
bservation that the phosphorylated proteins detected
fter exposure to virus are cytosolic suggests that these
roteins are not themselves viral receptors but rather are
eing phosphorylated in association with or in response
o viral entry.
To determine whether the induction of tyrosine phos-
horylation of these cellular cytosolic proteins is trig-
ered by the physical binding of HSV to cells alone or
equires viral entry, we compared the ability of a gL-
eletion virus grown on noncomplementing or comple-
enting cells to induce tyrosine phosphorylation. The
eletion of gL results in mutant virions that can bind to
ells but fail to penetrate (Roop et al., 1993; M. Novotny
nd P. G. Spear, unpublished data). For these studies,
tocks of KOS-gL86 harvested from complementing or
oncomplementing cells were prepared. The stock har-
ested from complementing 79VB4 cells had a titer of
3 108 pfu/ml on 79VB4 cells; no plaques were seen on
ero cells. In contrast, a stock of KOS-gL86 harvested
rom noncomplementing Vero cells had a titer of 4 3 103
fu/ml on 79VB4 cells and 1.5 3 103 pfu/ml on Vero cells.
he relative concentration of viral particles was deter-
ined by comparing the optical densitometry of the gD
and after Western blotting as described in Materials
FIG. 2. Localization of tyrosine phosphorylated proteins. Vero cells
ere exposed to HSV-1(F) for 5 min, harvested, and fractionated into
ytosolic, membrane, and Triton X-100-insoluble fractions. All three
ractions were analyzed by immunoblotting with anti-phosphotyrosine
ntibodies.nd Methods. iVero cells were exposed to equivalent concentrations
f KOS-gL86 particles grown on complementing or non-
omplementing cells for 5, 10, or 30 min; cell lysates
ere prepared; and immunoprecipitation and immuno-
lotting were performed as previously described. The
esults are shown in Fig. 3. Exposure of cells to KOS-
L86 gown on complementing cells resulted in the an-
icipated increase in tyrosine phosphorylation of p140
nd p80. p104 was not detected in these gels. In con-
rast, exposure of cells to KOS-gL86 grown on non-
omplementing cells failed to induce any discernible
ncrease in protein tyrosine phosphorylation. These re-
ults suggest that binding of virus to cell surface is not
ufficient to induce tyrosine phosphorylation but that
ather, phosphorylation occurs in association with or is
riggered by viral entry.
ffects of kinase or phosphatase inhibitors on
yrosine phosphorylation of proteins
To determine whether inhibition by kinase inhibitors or
timulation by phosphatase inhibitors of tyrosine phosphor-
lation affects the observed phosphorylation of p140, p104,
nd p80, Vero cells were incubated with specific inhibitors,
heir respective controls, or an equivalent concentration of
MSO carrier and then exposed to HSV-1(F) for 5 min. Cell
ysates were prepared and analyzed by immunoprecipita-
ion followed by immunoblotting with anti-phosphotyrosine
ntibodies. The results are shown in Fig. 4. The tyrosine
FIG. 3. Tyrosine phosphorylation of cellular proteins in the presence
f a gL-deletion virus. Vero cells were mock infected (lane 1) or
xposed to relatively equal particle numbers of KOS-gL86 virus grown
n complementing cells (gL2/79VB4) (lanes 2–4) or noncomplementing
ero cells (gL2/Vero) (lanes 5–7) for 5, 10, or 30 min as indicated. Cell
ysates were prepared and analyzed by immunoprecipitation and West-
rn blotting. The complemented virus induces tyrosine phosphorylation
f the p80 and p140 cellular proteins as indicated by the arrows,
hereas exposure of cells to the noncomplemented virus fails tonduce any detectable cellular phosphorylation of proteins.
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223ROLE OF TYROSINE PHOSPHORYLATION IN HSV ENTRYinase inhibitors genistein (100 mM), herbimycin A (10 mM),
nd tyrphostin B46 (100 mM) inhibited phosphorylation of
140, p104, and p80 by ;50% by densitometry compared
ith their respective controls. In contrast, the tyrosine
hosphatase inhibitor PAO (10 mM) stimulated the phos-
horylation of p140, p104, and p80 (2-fold increase by
ensitometry).
ffects of kinase inhibitors on viral infection
Next, we examined whether viral infection is affected
y pretreatment of cells with inhibitors of protein tyrosine
FIG. 4. Effects of kinase or phosphatase inhibitors on cellular protein
yrosine phosphorylation. Vero cells were preincubated with the follow-
ng kinase inhibitors, phosphatase inhibitor, control compounds, or
MSO vehicle alone for the times indicated in Materials and Methods
nd then exposed to HSV-1(F) for 5 min: genistein (100 mM), herbimycin
(10 mM), tyrphostin B46 (100 mM), PAO (10 mM), and genistin (100 mM)
s control for genistein and tyrphostin A1 (100 mM) as control for
yrphostin B46. Cell lysates were prepared and analyzed by immuno-
recipitation followed by immunoblotting with anti-phosphotyrosine
ntibodies.
FIG. 5. Effects of kinase inhibitors on viral plaque formation. Vero cell
ith the indicated kinase inhibitors, control compounds, or DMSO vehic
nfected with HSV-1(17)(dUTPase/LAT at an m.o.i. to yield 100–500 plaq
he presence of compound as a percentage of PFU formed in the pre
xperiments performed in duplicate, and the error bars indicate standard devinases (PTKs). Vero cells were pretreated with various
oncentrations of PTK inhibitors or controls at 37°C for
ppropriate time intervals. Subsequently, the cells were
xposed to virus, and infection was monitored using a
tandard plaque assay. Results are shown in Fig. 5. The
retreatment of cells with tyrphostin B46, but not the
nactive control compound tyrphostin A1, resulted in a
ignificant reduction in viral plaque formation (P 5 .0018,
tudent’s unpaired t test). Notably, pretreatment of the
iral particles, but not the cells, had no inhibitory effect
n subsequent infectivity (data not shown). Herbimycin A
id not inhibit plaque formation at concentrations of 10
M or less; higher concentrations were cytotoxic. Simi-
arly, genistein had little or no effect on viral plaque
ormation. Serine/threonine kinase inhibitors also had no
ffect on HSV infection (data not shown).
To evaluate whether the inhibitory effect of tyrphostin
46 on viral plaque formation could be explained by
nhibition of steps early in viral infection, we also exam-
ned viral immediate-early gene expression. Taking ad-
antage of an HSV-1 strain derived from HSV-1(17) that
ontains the Escherichia coli b-galactosidase gene un-
er the control of the viral dUTPase gene promoter, we
ompared viral infection of Vero cells pretreated with the
ame concentrations of inhibitors or controls. Cultures
ere assayed for b-galactosidase activity at 5 h after
nfection as previously described (Roller and Herold,
997). In preliminary studies, to control for any effects of
TK inhibitors on b-galactosidase expression itself, un-
nfected cells were transfected with the same b-galac-
osidase cassette and exposed to PTK inhibitors. The
TK inhibitors did not inhibit b-galactosidase expression
data not shown). As shown in Fig. 6, pretreatment of
ells with tyrphostin B46, but not the control compound
grown to near confluence in 6-well dishes and then were preincubated
e times indicated in Materials and Methods. Cells were subsequently
ll on control (DMSO) dishes. The results are presented as PFU/well in
of DMSO vehicle alone. Each point is the mean of two independents were
le for th
ues/we
senceiation.
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224 QIE, MARCELLINO, AND HEROLDyrphostin A1, reduced viral entry parallel to its effects on
iral plaque formation (P 5 .0002, Student’s unpaired t
est). Again, neither genistein nor herbimycin A signifi-
antly inhibited viral immediate-early gene expression.
DISCUSSION
The data presented here support the notion that HSV-1
nd HSV-2 entry is associated with phosphorylation of
ellular proteins and, presumably, with activation of sig-
al transduction pathways. Phosphorylation of proteins
ppears to be important for viral infection because the
retreatment of cells with tyrphostin B46, a known PTK
nhibitor, reduced viral immediate-early gene expression
nd plaque formation in parallel. Notably, the kinetics of
hosphorylation of cellular proteins parallel the kinetics
f viral entry. In previous studies, we and others have
emonstrated that it takes 5–15 min for 50% of wild-type
SV-1 or HSV-2 particles to penetrate Vero cells and
enetration plateaus within ;30 min (Gerber et al., 1995;
erold et al., 1991; McClain and Fuller, 1994). Similarly,
e found that the increased phosphorylation of p80,
104, and p140 could be detected within 5 min and
iminished by 30 min postinfection.
Interestingly, the exposure of cells to a gL-deletion
irus grown on noncomplementing cells, which binds but
ails to penetrate, did not induce any detectable protein
hosphorylation. This observation suggests that tyrosine
hosphorylation of p80, p104, and p140 requires more
han a physical binding of viral particles to cell surface
eceptors and, given the time course, suggests that
hosphorylation is associated with fusion of the viral
nvelope with the cellular plasma membrane.
The nature of the signal transduction pathway or path-
FIG. 6. Effects of kinase inhibitors on viral entry. Cells were preincuba
or the times indicated in Materials and Methods and then infected with
easuring b-galactosidase activity. Results are presented as the absorb
f the absorbance in the presence of DMSO carrier alone. Each point
riplicate, and the error bars indicate standard deviation.ays being activated and whether activation facilitates miral entry or subsequent early steps in infection are not
et known. The observation that tyrphostin B46, a syn-
hetic PTK inhibitor, blocks viral infection suggests that
iral invasion may involve pathways that include cyclin-
ependent kinase (cdk)2 activation. Tyrphostin B46 is a
otent inhibitor of cdk2. The finding that the naturally
ccurring PTK inhibitors genistein and herbimycin A
lock phosphorylation of p80, p104, and p140 but fail to
nhibit viral infection may reflect differences in selectivity,
otency, and assay conditions. For immunoprecipitation
tudies, cell lysates are prepared 5 min after the expo-
ure to virus. In contrast, for infectivity studies, infection
s assessed 5 h (b-galactosidase expression) or 24 h
plaque assays) postinfection. Possibly, cells begin to
ecover from the effects of genistein and herbimycin A.
It may be that the signal transduction pathway being
ctivated in association with HSV entry relates to those
ctivated by ligands binding to the recently identified Hve
oreceptors. The coreceptors identified include a novel
ember of the TNF/NGF receptor family, HveA, and two
embers of the immunoglobulin superfamily, HveB and
veC (Geraghty et al., 1998; Montgomeryet al., 1996;
arner et al., 1998; Whitbeck et al., 1997). The physio-
ogical role of these coreceptors has not yet been fully
lucidated. HveA binds to several members of the TNFR-
ssociated factor (TRAF) family (Marsters et al., 1997).
ransient transfection of HveA into human 293 cells
auses marked activation of nuclear factor-kB, JunN-
erminal kinase, and Jun containing transcription factor
P-1, suggesting that HveA is associated with signal
ransduction pathways that activate the immune re-
ponse (Marsters et al., 1997). Whether similar pathways
re activated during viral entry remains to be deter-
h the indicated kinase inhibitors, control compounds, or DMSO vehicle
(17)(dUTPase/LAT). At 5 h after infection, viral entry was quantified by
the presence of kinase inhibitor or control compound as a percentage
average of three independent experiments performed in duplicate orted wit
HSV-1
ance in
is theined.
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225ROLE OF TYROSINE PHOSPHORYLATION IN HSV ENTRYIt is also possible that the pathway being activated
uring viral entry is similar to pathway activated by FGF
r other growth factors. This follows from the observa-
ions that there is a requirement for HS by FGF and HSV.
GF binds to cell surfaces at both low- and high-affinity
ites. The low-affinity site represents binding of FGF to
S, whereas the high-affinity site represents binding to a
pecific tyrosine kinase receptor (Rapraeger et al., 1991;
ayon et al., 1991). Several models have been proposed
o explain the interaction of HS, FGF, and FGFR. For
xample, it has been suggested that HS–FGF interac-
ions induce a necessary conformational change such
hat FGF can be recognized by its specific tyrosine ki-
ase receptor. One could envision a similar model for the
nteractions of HSV with cell surface. For example, the
inding of HSV to cell surface HS might induce a con-
ormational change in either the virus, cell, or both, which
acilitates secondary interactions at the cell surface such
s the interaction of gD with Hve coreceptors and/or the
nteraction of other envelope glycoproteins with cell sur-
ace components. These interactions might culminate in
ctivation of a signal transduction pathway and trigger
iral–cell fusion.
At a biochemical level, there are several mechanisms
hat could explain how activation of signal transduction
athways might facilitate viral entry. Activation of signal
ransduction pathways can induce rearrangements of
he host cytoskeleton and thus facilitate viral entry. Such
mechanism has been shown to be important in the
nvasion of HeLa cells by Shigella (Dehio et al., 1995).
lternatively, activation of signal transduction pathways
ay facilitate viral entry by stimulating inositol phos-
hate metabolism and thus increasing calcium ion con-
entration. Calcium ions are required for fusion of a wide
ariety of biological membranes, including the fusion of
ome enveloped viruses with cell membranes (Papahad-
opouloset al., 1990). For example, binding of human
mmunodeficiency virus type 1 to the CD4 molecule in-
uces phosphatidylinositol-3-kinase (Briand et al., 1997;
imitrov et al., 1993). Ca21 also appears to play a role in
pstein–Barr virus penetration and HCMV cell fusion
Dugas et al., 1988; Keay et al., 1995).
Notably, protein phosphorylation has also been sug-
ested to be important for HCMV entry. HCMV initiates
nfection by binding to HS moieties on the cell surface.
ubsequently, HCMV envelope glycoprotein gH interacts
ith a 92.5-kDa cell membrane receptor. The 92.5- kDa
ell membrane protein appears to be tyrosine phosphor-
lated after exposure of the cells to HCMV (Keay and
aldwin, 1996). Pretreatment of the cells with PTK inhib-
tors blocks phosphorylation of this cellular membrane
eceptor and impedes viral entry.
Further studies are needed to identify the cytoplasmic
roteins p80, p104, and p140; to identify the signal trans-
uction pathway or pathways being activated by HSVnfection; and to determine how this activation facilitates biral infection. Viral entry is a complex process that has
ot yet been been defined at a molecular or biochemical
evel. The results reported in these studies suggest a
ovel approach to address the question of how HSV
nvades cells.
MATERIAL AND METHODS
ells and viruses
Vero cells were obtained from the American Type
ulture Collection and passaged in medium 199 supple-
ented with 5% FBS. The cell line 79VB4 (provided by P.
pear, Northwestern University) is a gL-expressing Vero
ell line and was passaged in medium 199 supple-
ented with 5% FBS and 200 mg/ml G418 (Montgomery
t al., 1996). Wild-type viral strains were HSV-1(KOS),
SV-1(F), and HSV-2(G). The recombinant HSV-
(17)(dUTPase/LAT) contains the E. coli b-galactosidase
ene under the control of the viral dUTPase promoter in
lace of both copies of the LAT genes and has been
reviously described (gift of Ed Wagner, University of
alifornia, Irvine) (Singh and Wagner, 1995). KOS-gL86 is
mutant in which the E. coli b-galactosidase gene re-
laces part of the gL open reading frame (gift of P. Spear,
orthwestern University) (Montgomery et al., 1996).
reparation of cell lysates
Nearly confluent Vero cell monolayers in 25-cm2 flasks
ere preincubated with serum-free medium for 24 h
efore infection. Cells were exposed to HSV at an m.o.i.
f 5 PFU/cell for 5, 10, or 30 min (or mock infected as
ontrols). The inoculum was removed, and the cells were
ashed once with ice-cold PBS (9.1 mM dibasic sodium
hosphate, 1.7 mM monobasic sodium phosphate, 150
M NaCl, pH 7.4) and harvested by scraping. Cells were
elleted by centrifugation and resuspended in lysis
uffer (1% Triton X-100, 50 mM Tris–HCl, pH 7.6, 40 mM
-glycerophosphate, 0.4 mM NaVO4, 0.1 mg/ml phenyl-
ethylsulfonyl fluoride, 8 mg/ml aprotinin, and 10 mg/ml
eupeptin). The supernatant (soluble fraction) and pellet
insoluble fraction) were separated by centrifugation at
6,000g, and the protein concentration of each fraction
as determined using the DC Protein Assay (Bio-Rad).
Alternatively, for fractionation into membrane, cytosol,
nd insoluble fractions, the scraped infected cells were
uspended in sonication buffer (50 mM Tris–HCl, pH 7.6,
0 mM b-glycerophosphate, 0.4 mM NaVO4, 0.1 mg/ml
henylmethylsulfonyl fluoride, 8 mg/ml aprotinin, and 10
g/ml leupeptin) instead of lysis buffer. Cells were then
onicated for two 1-s bursts. The sonicate was then spun
15 min, 100,000g), the supernatant containing the cyto-
olic proteins was removed, and the pellet containing
ell membrane and cell nuclei was washed once with
onication buffer. The pellet was then suspended in lysis
uffer, the lysate was spun for 5 min at 100,000g, and the
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226 QIE, MARCELLINO, AND HEROLDupernatant containing membrane proteins was har-
ested. The remaining pellet containing cytoskeletal,
roteins, and nuclei was dissolved in a buffer containing
% SDS and 10 mM Tris–HCl, pH 7.4.
mmunoprecipitation and immunoblot analyses
Equal concentrations of protein from each sample were
ixed with 5 ml of a monoclonal anti-phosphotyrosine anti-
ody coupled to agarose (0.5 mg IgG/0.25 ml agarose,
Y20-agarose; Santa Cruz Biotechnology, Inc., Santa Cruz,
A) in immunoprecipitation buffer (1% Triton X-100, 150 mM
aCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.2 mM
odium vanadate, 0.2 mM phenylmethylsulfonyl fluoride,
nd 0.5% Nonidet P-40). Samples were incubated for 1 h or
vernight at 4°C with end-over-end rotation. Unbound pro-
eins were removed by washing the agarose three times
ith lysis buffer, followed by brief spins in an Eppendorf
entrifuge. The pellet was suspended in 40 ml of SDS
ample buffer (100 mM Tris–HCl, pH 6.8, 1% b-mercapto-
thanol, 4% SDS, 0.2% bromphenal blue, 20% glycerol),
oiled for 2 min, and then loaded onto a 7.5% SDS–poly-
crylamide slab gel. Proteins were transferred to nitrocel-
ulose (Schleicher & Schuell) by Western transfer using the
rans-Blot SD Semi-Dry Electrophoretic Transfer Cell (Bio-
ad). The nitrocellulose was incubated overnight at 4°C in
BS (150 mM NaCl and 20 mM Tris–HCl, pH 7.5) containing
% skim milk and then for 2 h at room temperature in
BS–5% milk containing monoclonal anti-phosphotyrosine
ntibody (PY20; Transduction Laboratories, Lexington, KY)
1:500 dilution). After several washes in TBS, the nitrocellu-
ose blot was incubated with horseradish peroxidase-con-
ugated goat anti-mouse IgG diluted 1:1000 in TBS for 1 h at
oom temperature. The blot was rinsed several times and
eveloped using the ECL kit (DuPont, Boston, MA).
reparation and quantification of gL-deletion virus.
Vero and 79VB4 cells were inoculated with KOS-gL86 at
n m.o.i. of ;10 PFU/cell, and the virus was harvested after
days. The inoculum was a virus stock produced on com-
lementing cells (79VB4) and had a titer of ;1010 PFU/ml
n 79VB4 cells and 104 PFU/ml on Vero cells. The relative
oncentration of viral particles was determined by compar-
ng the relative amounts of gD band by optical densitometry
fter Western blotting. Several dilutions of samples of each
arvest were solubilized, and polypeptides were fraction-
ted by SDS–PAGE. After SDS–PAGE, the proteins were
ransferred to nitrocellulose by Western transfer. Western
lots were performed as described above. The antiserum
sed was a polyclonal rabbit anti-HSV gD (R72) (obtained
rom P. Spear, Northwestern University).
inase/phosphatase inhibitors
To determine the effect of tyrosine kinase or phospha-
ase inhibitors on protein phosphorylation, Vero cellsere preincubated with the following inhibitors and con-rol compounds diluted in DMSO or preincubated with an
quivalent concentration of DMSO alone at 37°C for the
ppropriate time intervals before exposure of the cells to
irus: 0.1–100 mM genistein or genistin (Sigma) 3 60 min;
.1–10 mM herbimycin A (Sigma) 3 16 h; 0.1–100 mM
yrphostin B46 or tyrphostin A1 3 30 min (Calbiochem);
nd 0.1–10 mM PAO (Sigma), an inhibitor of tyrosine
hosphatase, 3 60 min. The cells were then exposed to
irus as described, and immunoprecipitation and immu-
oblotting were performed.
To assay the effect of the kinase/phosphatase inhibitors
n viral infection, plaque assays or b-galactosidase ex-
ression assays were conducted as previously described
Roller and Herold, 1997). For plaque assays, cells in 6-well
ishes were treated with the appropriate inhibitor or control
ompound at the concentrations indicated and for the time
nterval described above and then exposed to HSV-
(17)(dUTPase/LAT) (200–500 PFU/well) for 15 min at 37°C.
ubsequently, the inoculum was removed, and cells were
reated with citrate buffer (50 mM sodium citrate, 4 mM KCl,
djusted to pH 3.0) to inactivate residual extracellular virus
nd washed three times. Plaques were counted after 24 h
f incubation using a modified blue-plaque assay. Infected
ells are fixed with 0.5% glutaraldehyde and permeabilized
ith 0. 5% Nonidet P-40. and plaques were visualized by
-gal overlay (0.5 mg/ml X-gal dissolved in ferric cyanide
olution). For the b-galactosidase expression assays, cells
n 96 well-dishes (5 3 104 cells/well) were treated with the
ppropriate inhibitor or control compound at the concen-
rations indicated and for the time interval described above
nd then exposed to HSV-1(17)(dUTPase/LAT) at an m.o.i. of
PFU/cell at 37°C. After a 1-h absorption period, cells were
reated with low pH citrate buffer to inactivate most of the
esidual extracellular virus. After a 5-h period, the inoculum
as removed, and cells were washed with PBS, fixed with
lutaraldehyde, and permeabilized with 0.1% Nonidet P-40
n PBS. To quantify the amount of b-galactosidase activity
reflecting viral entry), cells were incubated with o-nitro-
henyl-b-D-galactopyranoside (1 mg/ml in 0.1% Nonidet
-40) for 1 h at 37°C, and the absorbance (410 nm) of the
oluble dye product was determined.
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